Clinical Trial

Prospective Randomized Study of Accelerated Radiation Therapy (PRART)

Study acronym: PRART
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Patients with Stage 0 ductal carcinoma in situ (Tis (DCIS), Stage T1-T2, lymph node negative(N0) breast cancers will be randomized to receive whole breast radiotherapy with a concomitant boost to the tumor bed over 15 fractions (Arm 1, standard) versus 10 fractions (Arm 2, experimental).
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2019-11-21; most recent amendment 2026-05-05.
Status change: Recruiting → Active, Not Recruiting 2025-06-27
Status change: Active, Not Recruiting → Recruiting 2020-06-05
Status change: Recruiting → Active, Not Recruiting 2020-03-31
Status change: Not Yet Recruiting → Recruiting 2019-11-22
Trial Details
NCT Number NCT04175210
Lead Sponsor Weill Medical College of Cornell University
Conditions Breast Cancer
Enrollment 397 participants
Start Date 2019-11-21
Primary Completion 2025-07-15 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-07